BA
GMED icon

Bridgewater Associates’s Globus Medical GMED Stock Holding History

Bridgewater Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.8M Buy
351,974
+21,511
+7% +$1.83M 0.11% 149
2026
Q1 		$28.5M Buy
330,463
+46,213
+16% +$4.15M 0.13% 115
2025
Q4 		$24.8M Sell
284,250
-176,841
-38% -$13.4M 0.09% 166
2025
Q3 		$26.4M Buy
461,091
+24,452
+6% +$1.41M 0.1% 163
2025
Q2 		$25.8M Buy
436,639
+303,527
+228% +$19.6M 0.1% 149
2025
Q1 		$9.74M Buy
+133,112
New +$11M 0.05% 263
2024
Q4 		– Sell
-32,853
Closed -$2.35M – 743
2024
Q3 		$2.35M Sell
32,853
-96,509
-75% -$6.81M 0.01% 483
2024
Q2 		$8.86M Buy
129,362
+98,389
+318% +$5.88M 0.05% 263
2024
Q1 		$1.66M Sell
30,973
-78,316
-72% -$4.21M 0.01% 520
2023
Q4 		$5.82M Sell
109,289
-32,447
-23% -$1.58M 0.03% 345
2023
Q3 		$7.04M Buy
141,736
+56,425
+66% +$3.16M 0.04% 292
2023
Q2 		$5.08M Sell
85,311
-8,839
-9% -$504K 0.03% 309
2023
Q1 		$5.33M Buy
94,150
+3,321
+4% +$213K 0.03% 299
2022
Q4 		$6.75M Sell
90,829
-30,612
-25% -$2.08M 0.04% 309
2022
Q3 		$7.23M Sell
121,441
-3,779
-3% -$228K 0.04% 312
2022
Q2 		$7.03M Buy
125,220
+11,734
+10% +$771K 0.03% 408
2022
Q1 		$8.37M Buy
113,486
+26,807
+31% +$1.86M 0.03% 332
2021
Q4 		$6.26M Sell
86,679
-5,237
-6% -$380K 0.04% 251
2021
Q3 		$7.04M Sell
91,916
-7,504
-8% -$603K 0.04% 245
2021
Q2 		$7.71M Buy
+99,420
New +$7.07M 0.05% 257

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bridgewater Associates's GMED Position: Q2 2026 in Review

Bridgewater Associates increased its Globus Medical (GMED) stake by 6.5% in Q2 2026, buying an estimated $1.83M and bringing the position to 351,974 shares worth $27.8M. The position accounts for 0.11% of the portfolio, ranked #149.

Bridgewater Associates first reported a position in GMED in Q2 2021 and has held it in 20 quarters since. The position peaked at $28.5M in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Bridgewater Associates held 351,974 shares of Globus Medical worth $27.8M as of Q2 2026.
  • Bridgewater Associates bought 21,511 Globus Medical shares in Q2 2026, an estimated $1.83M.
  • Globus Medical made up 0.11% of Bridgewater Associates's portfolio in Q2 2026, its #149 holding.
  • Bridgewater Associates first reported a position in Globus Medical in Q2 2021 and has held it in 20 quarters since.
  • Bridgewater Associates's Globus Medical position peaked at $28.5M in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.